Jump to page content

Here, research into major widespread diseases - from cancer to cardiovascular diseases to infections - was to be integrated and strategically developed. The next step was to create a lighthouse in Berlin, the German capital, to reshape collaboration between university and non-university research. Schavan's colleague in the Berlin Senate, Jürgen Zöllner, supported the "Berlin Institute of Health" project, not least thanks to the generous donation from Johanna Quandt. The Charité, as the joint university medicine of Humboldt University and Freie Universität, was set as a partner on the clinical side; there were already connections to the MDC as an excellent center in basic research, which the BIH, founded in 2013, strengthened and expanded: Thus, translational medicine was anchored in the city of Berlin and also promoted throughout Germany.

BIH History Leporello

April 2013 The Founding Supervisory Board holds its constitutive meeting.
May 2013 Evaluation of Scientific Concept
July 2013 An international evaluation commission presents its assessment of the new institution’s scientific concept. The assessment is highly positive.
September 2013 The Head Office begins its work.
September-November 2013 On the basis of the scientific concept joint project groups formed by the Charité and MDC develop implementation plans for the research program.
October 2013 The members of the Scientific Advisory Board are nominated.
November 2013 A first funding call (for Collaborative Research Grants) is published.
December 2013 The Directorate develops the research and budget plan with detailed measures and milestones.
February 2014 The Scientific Advisory Board meets for its founding session.
April 2014 The first Collaborative Research projects begin their activities.
June 2014 The first pathfinder studies are chosen at the CRU.
September 2014 The first BIH professorship "Experimentelle Herz-Kreislaufforschung" is being established.
March 2015 The Berlin House of Representatives passes the "Gesetz zur Errichtung des Berliner Instituts für Gesundheitsforschung" (Legislation for the formation of the Berlin Institute of Health).
April 2015 The legislation enabling the formation of the Berlin Institute of Health is passed into effect.
January 2016 BIH operates as independent corporation under public law
June 2016 Supervisory Board approves “BIH Strategy 2026”
November 2016 Supervisory Board approves “Strategy Implementation Plan 2017–2020”
Januar 2017 The Digital Health Accelerator of the BIH is founded.
Oktober 2017 The first BIH Johanna Quandt Professor Petra Ritter is appointed.
November 2017 Opening of the BIH QUEST Center with BIH Chair Ulrich Dirnagl.
April 2018 Opening of BIH Digital Health Center with BIH Chair Roland Eils.
Dezember 2018 DFG supports Digital Clinician Scientist Program as an innovative career path of the BIH Academy.
Februar 2019 EU supports RESTORE project of BIH Regeneration with 1 Mio Euro.
Juni 2019 BIH Chair Christof von Kalle heads the Center for Clinical Studies of BIH and Charité.
Juli 2019 The Government and the State of Berlin sign the administrative agreement on the integration of the BIH into the Charité - Universitätsmedizin Berlin.
January 2020 Foundation of the new research focus Single Cells.
February 2020 BIH leads the BMBF-funded project CORD-MI (Collaboration on Rare Diseases) with almost 6 million euros.
April 2020 BIH Professor and Director of the Institute of Virology at Charité Christian Drosten receives "Special Award for Outstanding Communication of Science in the COVID-19 Pandemic".
July 2020 Symbolic topping-out ceremony at the ATIZ - the joint Outpatient, Translational and Innovation Center of BIH and Charité.
October 2020 Professor Christopher Baum becomes Chairman of the Board of BIH.
November 2020 Professor Georg Duda becomes BIH Chair for Engineering Regenerative Therapies.
January 2021 BIH becomes translational research area and third pillar of Charité - Universitätsmedizin Berlin. The MDC becomes a Privileged Partner of BIH.

Annual Reports